Fundamental discoveries and advances in cancer biology
Identifying new targets in order to propose innovative therapies.
The research we fund
Four connected areas, explained without jargon.
Why four areas and not forty
A foundation of our size funding a little of everything would change nothing anywhere. The Institute therefore chose four connected themes, based on the strengths already present at the CHUM Research Centre.
They feed one another: what fundamental research uncovers becomes a target, the target becomes a treatment, and the treatment is verified in patients.
The four areas
Precision medicine
Assigning better treatments to patients according to the specifics of their cancer.
Cancer immunotherapy
Waking the immune system so that it recognises and eliminates tumours.
Innovative therapies and research impact on patients
Offering therapies and interventions at the cutting edge of technology.
What we have that others do not
All four areas depend on the same resource: banks of tissue and clinical data built up over decades, thanks to patients who agreed to contribute to them.
- Recognised strengths in cancers of epithelial origin: breast, ovary, prostate.
- Fundamental researchers and clinicians working together on the same samples.
- A deliberate continuum, from the laboratory to the patient's bedside.
Understanding without being a scientist
La voix du cancer is the Institute's podcast, in eight episodes. Public figures closely touched by the disease meet researchers to explore recent advances and the most promising treatment paths. Hosted by science communicator Jean-Daniel Doucet, presented by La Roche-Posay. Available in French.
